Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach. | Crit Rev Immunol | 2024 | 38618727 | PubTator, text mining | PubMed |
| A novel role of PSMB9 in endothelial cells and atherosclerosis: beyond its canonical function in immunoproteasome. | Acta Pharmacol Sin | 2024 | 38570600 | PubTator, text mining | PubMed |
| Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. | Cell | 2024 | 38552610 | PubTator, text mining | PubMed |
| Genetic ablation of Lmp2 increases the susceptibility for impaired cardiac function. | Front Mol Biosci | 2024 | 38516190 | PubTator, text mining | PubMed |
| Investigation of shared genetic features and related mechanisms between diabetes and tuberculosis. | Int Urol Nephrol | 2024 | 38512440 | PubTator, text mining | PubMed |
| Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy. | Int J Mol Sci | 2024 | 38473926 | PubTator, text mining | PubMed |
| Proteasome composition in immune cells implies special immune‐cell‐specific immunoproteasome function. | Eur J Immunol | 2024 | 38458995 | PubTator, text mining | PubMed |
| Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary Sjögren's Syndrome: A public databases-based study. | PLoS One | 2024 | 38359008 | PubTator, text mining | PubMed |
| Recent advances in tissue repair of the blood-brain barrier after stroke. | J Tissue Eng | 2024 | 38304736 | PubTator, text mining | PubMed |
| Atopic dermatitis-associated genetic variants regulate LOC100294145 expression implicating interleukin-27 production and type 1 interferon signaling. | World Allergy Organ J | 2024 | 38298829 | PubTator, text mining | PubMed |
| Correction: Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation. | Mol Neurobiol | 2024 | 38291292 | PubTator, text mining | PubMed |
| Special Issue: "Inflammatory Signaling Pathways Involved in Gastrointestinal Diseases". | Int J Mol Sci | 2024 | 38279287 | PubTator, text mining | PubMed |
Comprehensive analysis revealed the immunoinflammatory targets of rheumatoid arthritis based on intestinal flora, miRNA, transcription factors, and RNA-binding proteins databases, GSEA and GSVA pathway observations, and immunoinfiltration typing. | Hereditas | 2024 | 38273392 | PubTator, text mining | PubMed |
| Non-bone-derived exosomes: a new perspective on regulators of bone homeostasis. | Cell Commun Signal | 2024 | 38273356 | PubTator, text mining | PubMed |
| The role and applications of extracellular vesicles in osteoporosis. | Bone Res | 2024 | 38263267 | PubTator, text mining | PubMed |
| Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression. | bioRxiv | 2024 | 38260430 | PubTator, text mining | PubMed |
| Update of Natural Products and Their Derivatives Targeting Epstein-Barr Infection. | Viruses | 2024 | 38257824 | PubTator, text mining | PubMed |
| IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry. | Medicina (Kaunas) | 2024 | 38256421 | PubTator, text mining | PubMed |
| Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness. | Cancers (Basel) | 2024 | 38254830 | PubTator, text mining | PubMed |
| Can the Epstein-Barr Virus Play a Role in the Development of Prostate Cancer? | Cancers (Basel) | 2024 | 38254816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=8